# Neprilysin Inhibitor / ARB (ARNI)

## Sacubitril/Valsartan (Entresto)

- Start 48 hours after last ACE-I dose

### Starting Dose
- 24/26 mg PO BID if: naive to ACE-I/ARB, ≤10 mg Enalapril equivalent, eGFR <30, or hepatic impairment (Child-Pugh B)
- 49/51 mg PO BID if: >10 mg Enalapril equivalent

### Incremental Doses
24/26 mg → 49/51 mg → 97/103 mg PO BID

### Maximum Dose
97/103 mg PO BID

### Contraindications
- Angioedema (ACE-I, ARB, neprilysin inhibitor)
- Concurrent ACE-I use (<48 hr separation)
- Pregnancy
- Severe hepatic impairment (Child-Pugh C)

### Hold / Discontinue If
- K⁺ >5.5 mEq/L (hold)
- Creatinine ↑ >30% (hold, reassess 1–2 weeks)
- eGFR <20 mL/min (caution)
- SBP <80–90 mmHg with symptoms
- Angioedema or hyperkalemia >6.0 mEq/L (discontinue)